Evaluation of Cardioprotective activity of Asparagus racemosus against Doxorubicin induced cardiotoxicity in albino rats: an experimental study

Pinki Vishwakarma; Manisha Chatterjee; Monica Sharma; Manish Saini; Rajkumar Goel; K. K. Saxena

doi:10.18203/2319-2003.ijbcp20192673

Authors

Pinki Vishwakarma Department of Pharmacology, Lala Lajpai Rai Memorial Medical College Meerut, Meerut, Uttar Pradesh, India
Manisha Chatterjee Department of Pharmacology, Lala Lajpai Rai Memorial Medical College Meerut, Meerut, Uttar Pradesh, India
Monica Sharma Department of Pharmacology, Lala Lajpai Rai Memorial Medical College Meerut, Meerut, Uttar Pradesh, India
Manish Saini Department of Pharmacology, Lala Lajpai Rai Memorial Medical College Meerut, Meerut, Uttar Pradesh, India
Rajkumar Goel Department of Pharmacology, Lala Lajpai Rai Memorial Medical College Meerut, Meerut, Uttar Pradesh, India
K. K. Saxena Department of Pharmacology, Lala Lajpai Rai Memorial Medical College Meerut, Meerut, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20192673

Keywords:

Asparagus racemosus, Cardiotoxicity, Carvedilol, Doxorubicin

Abstract

Background: Cardiotoxicity is one of the most feared side effects of anticancer agents like Doxorubicin. Asparagus racemosus is a widely used medicinal plant in Indian system of medicine known for its antioxidant activity. In certain studies ethanol extract of Asparagus racemosus has shown to possess cardioprotective activity in experimental animals while in some other studies cardioprotective potential of Asparagus racemosus has not been demonstrated. Therefore, due to the controversial action, the present study was designed to explore the cardioprotective effect of aqueous effect of Asparagus racemosus against doxorubicin induced cardiotoxity.

Methods: Following approval from Institutional Animal Ethics Committee of L.L.R.M Medical College registered under CPCSEA, India, this study was conducted in which 30 rats were randomized into five groups of six rats each. Group I received 2 ml/kg b.w. normal saline p.o for 21 days, group II apart from receiving pellet diet and normal saline for 21 days were treated with Doxorubicin in a single dose of 20 mg/kg intraperitoneally on the 21^st day, group III and group IV received aqueous extract of Asparagus racemosus in doses of 250 mg/kg/day and 500 mg/kg/day respectively p.o. for 21 days followed by administration of Doxorubicin (20 mg/kg i.p.) on the 21^st day, Group V received Carvedilol in doses of 30 mg/kg/day p.o. for 21 days followed by administration of Doxorubicin (20mg/kg i.p) on the 21^st day. Then they were anaesthetized and blood sample was collected from abdominal aorta for performing blood test i.e. Creatinine kinase MB fraction (CK-MB), Lactate dehydrogenase (LDH), Serum glutamate oxaloacetate transaminase (SGOT), Serum glutamate pyruvate transaminase (SGPT). After blood collection the animals were sacrificed and heart was dissected out for histopathological study. The data obtained was organized and analysed by suitable statistical methods i.e. ANOVA followed by Post Hoc test.

Results: CK-MB, LDH, SGOT and SGPT levels were found to be significantly raised (p<0.001) in Doxorubicin treated group. Asparagus racemosus pretreated groups exhibited significant limitation (p<0.001) in rise in levels of CK-MB,LDH,SGOT and SGPT levels in a dose dependent manner following Doxorubicin administration which were comparable to the group treated with the standard cardioprotective drug Carvedilol. Histopathological changes further corroborated cardioprotective potential of Asparagus racemosus.

Conclusions: The present study concluded that aqueous extract of Asparagus racemosus possess cardioprotective potential against Doxorubicin induced cardiotoxicity.

Metrics

Metrics Loading ...

References

Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Assosiation Statistics Committee and Stroke Statistics subcommittee, Circulation. 2017;117(5):25-146.

Ewer MS, Vooletich MT, Durand JB. Reversibility of trastuzumab-related cardiotoxicity: New insights based on clinical course and response to medical treatment. J Clin Oncol. 2005;23(31):7820-6.

Singh G, Sing AT, Abraham A, Bhat B, Mukherjee A, Verma R, et al. Protective effects of Terminalia arjuna against doxorubicin induced cardiotoxicity. J Ethanopharmacol. 2008;117(1):123-9.

Von Hoff DD, Layard MW, Basa P, Davis HL Jr, Von Hoff AL, Rozencweig M, et al. Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med. 1979;91(5):710-7.

Kalay N, Basar E, Ozdogru I, Er O, Cetinkaya Y, Dogan A. Protective effects of carvedilol against anthracycline-induced cardiomyopathy. J Am Coll Cardiol. 2006;48(11):2258-62.

Varshney P, Vishwakarma P, Sharma M, Saini M, Bhatt S, Singh G, et al. Cardioprotective effect of Solanum nigrum against doxorubicin induced cardiotoxicity-an experimental study. Int J Basic Clin Pharmacol. 2016;5(3):748-50.

Kalay N, Basar E, Ozdogru I, Er O, Cetinkaya Y, Dogan A. Protective effects of carvedilol against anthracycline-induced cardiomyopathy. J Am Coll Cardiol. 2006;48(11):2258-62.

Matsui H, Morishima I, Numaguchi Y, Toki Y, Okumura K, Hayakawa T. Protective effects of carvedilol against doxorubicin-induced cardiomyopathy. Life Sci. 1999;65(12):1265-74.

Sharma K, Bhatnagar M. Asparagus racemosus (Shatavari):A versatile female tonic. Int J Pharm Biol Arch. 2011;2(3):855-63.

Ahmad S, Ahmed S, Jain PC. Chemical examination of Shatavari Asparagus racemosus.Bull Medico Ethano Bot Res.1991;12(3-4):157-60.

Goyal RK, Singh J, Lal H. Asparagus racemosus an update. Indian J Med Sci. 2003;57(9):408-14.

Kamat JP, Boloor KK, Devasagayam TP, Venkatachalam SR. Antioxidant properties of Asparagus racemosus against damage induced by gamma radiation on rat liver mitochondria. J Ethanopharmacol. 2000;71(3):425-35.

Handa SS, Suri OP, Gupta VN, Suri KA, Satti NK, Bhardwaj V. Oligospirostanoside from Asparagus racemosus as immunomodulator, US Patent No.6649745.2003.

Joshi T, Sah SP, Singh A. Antistress activity of ethanolic extract of Asparagus racemosus wild roots in mice. Indian J Exp Biol. 2012;50(6):419-24.

Singh GK, Garabadu D, Muruganandam AV, Joshi VK, Krishnamurthy S. Antidepressant activity of Asparagus racemosus in rodent models. Pharmacol Biochem Behav. 2009;91(3):283-290.

Wiboonpun N, Phuwapraisirisan P, Tippyang S. Identification of antioxidant compound from Asparagus racemosus. Phytother Res. 2004;8(9):771-3.

Boger DL, Mitscher LA, Mullican MD, Drake SD, Kitos P. Antimicrobial and cytotoxic properties of 9,10 dihydrophenanthrene: Structure activity studies on juncusol. J Med Chem. 1985;28(10):1543-7.

Mandal SC, Nandy A, PalM, Saha BP. Evaluation of antibacterial activity of Asparagus racemosus wild root. Phytother Res. 2000;14(2):118-9.

Acharya SR, Acharya NS, Bhangale JO, Shah SK, Pandya SS. Antioxidant and hepatoprotective action of Asparagus racemosus Wild root extracts. Indian J Exp Biol. 2012;50(11):795-801.

Joshi JDS. Chemistry of Ayurvedic crude drugs: Part VIII: Shatavari 2. Structure elucidation of bioactive shatavarin I and other glycosides. Indian J Chem Section B Organ Chem. 1988;27(1):12-6.

Byrne JA, Grieve DJ, Cave AC, Shah AM. Oxidative stress and heart failure. Arch Mal Coeur. 2003;96:214-21.

Simunek T, Sterba M, Popelova O, Adamcova M, Hrdina R, Gersl V. Anthracycline induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron. Pharmacol Rep. 2009;61(1):154-71.

Puri A, Maulik SK, Ray R, Bhatnagar V. Electrocardiographic and biochemical evidence for the cardioprotective effect of vitamin E in doxorubicin-induced acute cadiotoxicity in rats. Eur J Pediatr Surg. 2005;15(6):387-91.

Haed S, Barshack I, Luboshits G, Wexler D, Deutsch V, Keren G, et al. Erythropoietin improves myocardial performance in doxorubicin-induced Cardiomyopathy. Eur Heart J. 2006;27(15):1876-83.

Akinmoladun AC, Ibukun EO, Afor E, Akinrinlola BL, Onibon TR, Akinboboye AO, et al. Chemical constituents and antioxidant activity of Alstonia boonei. Afr J Biotechnol. 2007;6(10):1197-201.

Guleria S, Tiku AK, Singh G, Koul A, Gupta S, Rana S. In vitro antioxidant activity and phenolic contents in methanol extracts from medicinal plants. Journal of plant biochemistry and biotechnology. 2013 Jan 1;22(1):9-15.

Suchalatha S, Devi SCS. Protective effect of Terminalia chebula against experimental myocardial injury induced by isoproterenol. Indian Biol. 2004;42(2):174-8.

Panda VS, Naik SR. Cardioprotective activity of ginkgo bilobaphytosomes in isoproterenol induced myocardial necrosis in rats: a biochemical and histoarchitectural evaluation. Exp Toxicol Pathol. 2008;60(4-5):397-404.

Saad SY, Najjar TA, AI-Rikabi AC. The preventive role of desferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats. Pharmacol Res. 2001;43(3):211-8.

Roy RN, Bhagwager S, Chavan SR, Dutta NK. Preliminary pharmacological studies on extracts of root of Asparagus racemosus (Satavari), Willd, Lilliaceae. J Res Indian Med. 1971;6:132-8.

Premanath R, Lakshmidevi N. Studies on antioxidant activities of Tinospora cordifolia leaves using in vitro models. J Am Sci. 2010;6(10):736-42.